Nicotine, acting through nicotinic acetylcholine receptors (nAChRs), increases the firing rate of both orexigenic agouti-related peptide (AgRP) and anorexigenic proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (ARC), yet nicotine and other nAChR agonists decrease food intake in mice. Viralmediated knockdown of the β4 nAChR subunit in all neuronal cell types in the ARC prevents the nicotinic agonist cytisine from decreasing food intake, but it is not known whether the β4 subunit is selectively expressed in anorexigenic neurons or how other nAChR subtypes are distributed in this nucleus. Using translating ribosome affinity purification (TRAP) on ARC tissue from mice with ribosomes tagged in either AgRP or POMC cells, we examined nAChR subunit mRNA levels using real-time PCR. Both AgRP and POMC cells express a comparable panel of nAChR subunits with differences in α7 mRNA levels and a trend for difference in α4 levels, but no differences in β4 expression. Immunoprecipitation of assembled nAChRs revealed that the β4 subunit forms assembled channels with α3, β2 and α4, but not other subunits found in the ARC. Finally, using cell type-selective, virally delivered small hairpin RNAs targeting either the β4 or α7 subunit, we examined the contribution of each subunit in either AgRP or POMC cells to the behavioural response to nicotine, refining the understanding of nicotinic regulation of this feeding circuit.
| INTRODUCTION
Despite the well-documented and well-known health risks of cigarette smoking, many smokers report that they continue to smoke in part because of nicotine's association with appetite suppression and leaner body mass (Albanes, Jones, Micozzi, & Mattson, 1987; Chiolero, Faeh, Paccaud, & Cornuz, 2008; Klesges et al., 1997) . Like smoking in humans, nicotine reduces food intake and weight gain in rodent models (Frankish et al., 1995; Grunberg, Bowen, & Winders, 1986; Mineur et al., 2011; Winders & Grunberg, 1990) . In both the brain and the periphery nicotine acts on nicotinic acetylcholine receptors (nAChR), cation channels made up of a combination α-and β-type subunits arranged as a pentamer around a central pore (Albuquerque, Pereira, Alkondon, & Rogers, 2009; Morales-Perez, Noviello, & Hibbs, 2016) . The identity of the individual subunits and the stoichiometry of α and β subunits within an assembled nAChR determine many channel properties, including sensitivity to both endogenous and exogenous ligands, kinetics of ligand binding, the amplitude and identity of ionic currents that flow through the channel, and channel open time (George et al., 2017; Lucero et al., 2015; Mazzaferro, Bermudez, & Sine, 2016; Stokes & Papke, 2012) . In addition, each nicotinic subunit is expressed in distinct, though overlapping, patterns in many cell types throughout the brain (Sargent, 1993) . Accordingly, specific nAChR subunits play dissociable roles in different behavioural paradigms. For example, mice lacking the β2 subunit demonstrate abnormal avoidance learning and will not self-administer nicotine, unlike their wild-type siblings (Picciotto et al., 1995 (Picciotto et al., , 1998 , β4 knockout mice show greatly decreased symptoms of nicotine withdrawal compared with wild-type mice (Salas, Pieri, & De Biasi, 2004) , and knockdown of the α5 subunit induces higher levels of nicotine self-administration, likely by reducing aversive consequences of nicotine intake (Fowler, Lu, Johnson, Marks, & Kenny, 2011) .
Nicotine affects food intake and fat storage through actions of nAChRs at many levels in the brain and periphery (Jo, Talmage, & Role, 2002; Stojakovic, Espinosa, Farhad, & Lutfy, 2017; Zoli & Picciotto, 2012) . The α3β4* nAChR full agonist cytisine, which also acts as a low-affinity agonist of α7 nAChRs and a partial agonist of α4β2* nAChRs in mice (Papke & Heinemann, 1994; Peng et al., 2013; Stokes & Papke, 2012) , acutely reduces food intake (* notation indicates the presence of variable additional subunits). This effect is abolished by viral-mediated knockdown of the β4 nAChR subunit in the arcuate nucleus of the hypothalamus (ARC; Mineur et al., 2011) , a brain area known to affect appetite. The ARC is a central node in the hypothalamus regulating food intake and its two main cell populations, agouti-related peptide (AgRP) and pro-opiomelanocortin (POMC) expressing neurons, induce hunger and satiety, respectively (Aponte, Atasoy, & Sternson, 2011; Cansell, Denis, Joly-Amado, Castel, & Luquet, 2012; Fenselau et al., 2016; Kim et al., 2015; Krashes et al., 2011; Sternson & Atasoy, 2014; Zhan et al., 2013) . The reduction in food intake and weight gain due to β4 agonism have been supported by additional studies using cytisine (Grebenstein, Harp, & Rowland, 2013) and another β4 agonist, levamisole (Lewis, Yakel, & Pandya, 2017) . Knockout of the POMC gene or small hairpin RNA (shRNA)-mediated knockdown of melanocortin receptors in the paraventricular nucleus also diminishes the ability of cytisine to decrease food intake (Mineur et al., 2011) , suggesting that activation of β4-containing nAChRs in response to nicotinic agonists leads to activation of the melanocortin pathway, signalling satiety and thus yielding reduced food intake and long-term reductions in weight gain. One possibility to explain this relationship is that β4 nAChR subunits could be selectively or preferentially expressed on POMC neurons, regulating the increase in activity of POMC neurons in response to cytisine and nicotine (Huang, Xu, & van den Pol, 2011; Mineur et al., 2011; Rubinstein & Low, 2011) . However, β4 nAChR subunit expression on other cell types cannot yet be ruled out, as the localization of nAChR expression in the different cell types in ARC has not yet been examined. Further, as cytisine is also a full agonist at α7 receptors with a lower EC 50 than for β4* receptors (Papke & Porter Papke, 2002; Stokes & Papke, 2012) , these receptors could be playing a synergistic role in controlling food intake, and the role of this receptor class has not been examined in the ARC. Finally, signalling through either α7 or β4* containing nAChRs may regulate the feeding response to the broader agonist nicotine.
This study was designed to characterize nAChR subunit expression in the ARC comprehensively, with a specific focus on how nAChRs on AgRP and POMC neurons might contribute to reductions in food intake in response to nicotinic agonists, including nicotine and cytisine. We used a genetic method to perform translating ribosome affinity purification (bacTRAP) to isolate actively translated mRNAs from AgRP or POMC cells, to analyse enrichment of nAChR subunit translation in either cell type compared with the hypothalamus in general, as well as to compare relative subunit mRNA translation between AgRP and POMC cell types directly. To identify which nAChR subunits form assembled pentameric receptors in the hypothalamus overall, and in ARC specifically, we used subunit-selective antibodies to immunoprecipitate nAChR subtypes, and further sequential immunoprecipitation to determine which subunits assemble with the β4 subunit to form nAChRs. We determined the expression of the cholinergic cell markers choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) in AgRP and POMC cells to determine whether neurons within the ARC show a cholinergic phenotype and may be engaged in local acetylcholine (ACh) release. Finally, with the use of novel cell type-selective shRNA-carrying viruses targeting the β4 or α7 nAChR subunits, we determined whether expression of these subunits in AgRP or POMC cells affected the acute feeding response to nicotine and cytisine.
| METHODS

| Animals
For bacTRAP experiments, AgRP and POMC-eGFP-RPL10a transgenic mice were made in the same way as Pdyn-eGFPRPL10a mice (Allison et al., 2015) , except that pronuclear injection was done with C57BL/6J embryos. Briefly, eGFPRPL10a as a fusion gene was cloned immediately downstream of the ATG of the AgRP and POMC genomic sequence in the BAC backbone (RP24-297L5 and RP23-168O9, respectively). Resulting N0 pups were bred to C57BL/6J to produce N1 pups which were screened for eutopic transgene expression. Selected founders were maintained on C57BL/6J background and inter-crossed to produce pups for the study.
For immunoprecipitation (IP) experiments and immunohistochemistry adult male C57BL/6J (>8 weeks) mice were purchased from Jackson Laboratories (Bar Harbor, ME) and group housed. Hypothalamus samples for IPs from β2 KO mice were a generous gift of Dr. Michael J Marks (Institute for Behavioral Genetics, University of Colorado, Boulder, USA). For shRNA-mediated knockdown validation experiments, GAD65-IRES-Cre mice (Jackson Labs Bar Harbor, ME; Stock #010802) and ChAT-IRES-Cre mice (Jackson Labs strain B6;129S6-Chattm2(cre)Lowl/J, Stock:006410; Bar Harbor, ME) were bred in house to C57BL/6J mice. AgRP-IRES-Cre mice ((Agrptm1-cre)Lowl, Jax #012899) and POMC-Cre (Tg (Pomc1-cre)16Lowl/J) mice were bred in house to C57BL/6J mice and used for behavioural experiments. AgRP-Cre wild-type littermates were used for pharmacological feeding tests.
All animals were maintained in a temperature controlled vivarium (21-23°C) on a 12-hr light-dark cycle (lights on 7:00 a.m.) and housed five per cage with food and water available ad libitum, unless otherwise specified. All experiments were performed according to protocols approved by the Yale University, Rockefeller University and/ or University of Colorado, Boulder Animal Care and Use Committees.
| Drugs
All drug solutions were prepared in sterile phosphatebuffered saline and administered intraperitoneally. Nicotine hydrogen tartrate salt was provided through the NIDA drug supply program. All nicotine doses are reported as free base (Matta et al., 2007) . Cytisine was purchased from SigmaAldrich (St. Louis, MO).
| Tissue collection
| BacTRAP
Ten adult bacTRAP mice (>8 weeks) of the same sex were pooled for each sample. Ten AgRP-TRAP and 10 POMC-TRAP samples (five male and five female for each) were collected from EGFPL10a transgenic mice, and tissue was dissected and processed as previously described (Heiman, Kulicke, Fenster, Greengard, & Heintz, 2014; Heiman et al., 2008) . Briefly, mice were rapidly decapitated and the hypothalami of 10 bacTRAP transgenic mice of the same line and sex were manually dissected in dissection buffer (2.5 mM HEPES-KOH [pH 7.4], 35 mM Glucose, 4 mM NaHCO 3 in HBSS). Pooled tissue was immediately homogenized in a Teflon-glass homogenizer (300 rpm, six strokes, 900 rpm, six strokes) with ice-cold homogenization buffer (10 mM HEPES-KOH [pH 7.4], 150 mM KCl, 5 mM MgCl2, 0.5 mM dithiothreitol, protease inhibitors, Rnasin and 100 μg/ml cycloheximide). 20 μL of homogenate was saved at this stage to be used for total RNA analysis. The remaining homogenate was centrifuged for 10 min (2,000 x g) at 4°C. NP-40 (EMD Biosciences, San Diego, CA) and 1,2-diheptanoyl-sn-glycer o-3-phosphocholine (DHPC; Avanti Polar Lipids, Alabaster, AL) were added to the supernatant at a final concentration of 1% and 30 mM, respectively. Samples were incubated on ice for 5 min then centrifuged at 20,000 x g for 15 min.
The resulting supernatant was transferred to mouse anti-GFP (custom)-coated MyOne magnetic Dynabeads (Invitrogen) and incubated on a slow rotator at 4°C for 16-18 hr. Dynabeads were washed three times with wash buffer (10 mM HEPES-KOH [pH 7.4], 5 mM MgCl2, 350 mM KCl, 1% NP-40, 0.5 mM dithiothreitol, Rnasin, 100 mg/ml cycloheximide, RNase inhibitors, 3% BSA and 500 ng/ml poly[d(I-C)]). Beads were resuspended in 100 μl lysis buffer (Stratagene Absolutely RNA NanoRNA kit) or RLT buffer (Qiagen RNeasy kit) with β-ME added, vortexed and incubated at room temperature for 10 min. Beads were separated on a magnet and the supernatant was collected. 200 ng poly[d(I-C)] was added to the collected supernatant. RNA was quantified and checked for quality on a Bioanalyzer 2100 using RNA Picochip (Agilent Technologies, Santa Clara, CA). Remaining RNA was frozen at −80°C until it was converted to cDNA.
| Immunoprecipitation and qualitative PCR
Adult C57BL/6J mice were killed via decapitation and brains were removed. For IP experiments using the whole hypothalamus, each experiment was conducted on the pooled tissue from 10 mice (3-4 replicate experiments). For specific ARC dissections, brains were removed after decapitation, the hypothalamic disc was removed from the ventral surface of the brain, and a 1.2 mm punch surrounding the 3rd ventricle containing the ARC was taken and immediately frozen on dry ice (Supporting Information Figure S1 for diagram). For these dissections, ARC punches were pooled before IP, resulting in tissue from 20 mice being used for each of two immunoprecipitation replicates. For PCR each animal was one biological replicate, two animals total. After collection, tissue was stored at −80°C until it was used for IP or for mRNA extraction.
| cDNA preparation
For qualitative PCR, TRAP and viral validation experiments, RNA was extracted from tissue using an RNeasy Lipid Tissue Mini Kit following the manufacturer's protocol (Qiagen, Valencia, CA). The concentration of extracted mRNA was measured with a spectrophotometer (NanoDrop ND-1000; Thermo Scientific, Waltham, MA). RNA extracted using the RNeasy kit or isolated via the TRAP protocol was converted to double-stranded cDNA using Qiagen QuantiTect Reverse Transcription Kit according to the manufacturer's instructions. cDNA was generated using the maximum possible RNA for qualitative PCR (1.2 μg), bacTRAP input and bound samples (4-89 ng), 20 ng RNA for medial habenula (MHb) samples and 125 ng RNA for GAD65-Cre ventral hippocampus (vHipp) samples. Converted cDNA was stored at −20°C or −80°C until PCR analysis.
| Qualitative PCR
ARC cDNA was diluted 1:20 and 3 μl of this working solution was used in a 20 μl PCR mixture using Taq polymerase (Roche). Primers for the α2-7 and β2-4 subunits are listed in Table 1 . PCR mixtures were incubated in a DNAEngine Peltier Thermal Cycler (Bio-Rad) under the following conditions: 95°C 1 min, (95°C 30 s, 58°C 30 s, 72°C 30 s) × 40 cycles, 72°C 5 min. PCR products were run via electrophoresis on a 1.5% agarose gel containing ethidium bromide at 150 V for 45 min. Gels were visualized on a UV box, and images were taken using Foto Analyst PC Image software (Fotodyne Inc, Hartland, WI). One representative band is shown for each subunit. 
| Analysis
For bacTRAP samples, fold change, was calculated using the 2 − ΔΔCt method (Goni, García, & Foissac, 2009 ) with HPRT used as the reference gene. To determine fold enrichment, the total hypothalamic homogenate was used as a reference group to which the TRAP purified samples were compared. To determine differences in expression between AgRP and POMC cells, the POMC group was used as the reference group to which AgRP samples were compared. The resulting fold change measures were graphed and used for statistical analysis between groups. Individual t tests were run for each gene analysed. Efficiency of β4 knockdown was quantified using the 2 − ΔΔCt method with tbp1 as the reference gene, and Cre-mice as the reference group. For analysis of α7 knockdown, the 2 −ΔΔCt method was used with HPRT as the reference gene and AAV-dsRed-Sico-Scr shRNA as the reference group. The resulting fold change measure was graphed and used for statistical analysis.
2.7 | nAChR Immunoprecipitation 2.7.1 | Antibody production and characterization Affinity-purified, subunit-specific, polyclonal antibodies were used for the detection of nAChR subunits. The production of antibodies respected the guidelines established by the Italian Council on Animal Care and was approved by Italian Government Decree No. 2/2010. Subunit-specific polyclonal antibodies were produced in rabbits against peptides derived from intracytoplasmic loop (CYT) regions of the α2, -α3, -α4, -α5, α6, -β2, -β3, β4 rodent (mouse or rat) or human subunit sequences, and affinity purified and characterized as previously described (Gotti et al., 2008; Grady et al., 2009) . For the α3 and β4 subunits, polyclonal antibodies directed against the rodent COOH α3 (CQPLMARDDT) and the rodent β4 (CGLPPLFQIHAPSKDS) peptides were also used.
| Tissue homogenates and Triton
X-100 extracts
The dissected frozen whole hypothalami or ARC nuclei were homogenized using a glass potter and washed in 50 mM Tris-HCl pH 7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2.5 mM CaCl 2 and 2 mM PMSF by centrifugation twice. The resulting pellets were suspended in the same buffer containing a mixture of 20 μg/ml of each of the following protease inhibitors: leupeptin, bestatin, pepstatin A and aprotinin. Triton X-100 at a final concentration of 2% was added to the washed membranes and extraction was performed for 2 hr at 4°C as previously described (Gotti et al., 2008) .
Protein content of the membranes and 2% Triton X-100 extracts was measured using the bicinchoninic acid protein assay (Pierce, Rockford, IL, USA) with bovine serum albumin as the standard. Epibatidine at 4°C. Following overnight incubation, nAChRs were captured using DEAE-Sepharose ™ Fast flow (GE Healthcare, Uppsala, Sweden). Bound receptors were eluted with 1N NaOH and counted after addition of the scintillation mixture (filter count, GE Healthcare, Uppsala, Sweden) in a Tri-Carb 2100TR β-counter (Perkin Elmer) counter. Nonspecific binding (averaging 5%-10% of total binding) was determined in parallel samples containing 100 nM unlabelled epibatidine.
| [ 3 H]-Epibatidine binding studies
| Immunoprecipitation of [ 3 H]-Epibatidine-labelled nAChRs by subunitspecific antibodies
Extracts (100 μl), were incubated with 1 μM α-bungarotoxin followed by incubation with 1 nM [ 3 H]-Epibatidine, then incubated overnight with a saturating concentration (10 μg) of affinity-purified anti-subunit IgG (anti-α2, -α3, -α4, -α5, -α6, -β2, -β3, -β4) or control IgG bound to Sepharose-Protein A (GE). Immunoprecipitates were recovered by centrifugation (5 min at 2,400 x g).
[ 3 H]-Epibatidine binds to assembled heteromeric nAChRs, but it does not bind to subunits that are not associated with a subunit partner. Therefore, once the presence of a particular nAChR subunit is established with an antibody in the first IP assay, the subunit(s) it is associated with can be determined by performing a second IP on the resultant supernatant with a different antibody. The rationale for this sequential procedure is that if two (or more) different subunits are part of the same receptor, then initial IP of that receptor with an antibody directed at one subunit will decrease the amount of the receptor available in the remaining supernatant of the sample for IP with a subsequent antibody. For the sequential IP assays, a fixed amount of the clear [ 3 H]-Epibatidine-labelled supernatant remaining after IP with the first antibody (anti-α2, -α3, -α4, -α5, -α6, -β2, -β3, -β4) was incubated with a saturating concentration (10 μg) of anti-β4 antibody bound to protein A and the IP steps were then repeated, as described above. In control studies, the number of solubilized nAChRs measured with [ 3 H]-Epibatidine was stable when incubated in the presence of control IgG over the time course of the sequential IP procedure.
| Plasmid design and viral packaging
Short-hairpin RNAs targeting the β4 and α7 nAChR subunits were designed using siRNA Wizard (InvivoGen, www. invivogen.com; San Diego, CA; previously described in Mineur et al., 2011 Mineur et al., , 2013 Mineur et al., , 2016 and ligated into a pAAVdsRed-Sico plasmid designed to restrict shRNA expression to cells that express Cre-recombinase (described in Wohleb et al., 2016) . Target sequences used were (5′-3′): β4 RNAi 1: GAGGAGAAGCTGATGGATGATCTC; β4 RNAi 2: GTTGTACAACAATGCCGATGGGAC; α7 RNAi 1: GGCTGTACAAGGAGCTGGTCAAGA; α7 RNAi 2: AGCCCTGGCTTTGCTGGTATTCTT; α7 RNAi 3: GCCAG GATGAGAGTGAGGTGATCT. A scrambled RNAi sequence not targeting any murine mRNAs (SCR) was also used: GCCAGATTTCTCAGGTGATAA. For β4shRNAs, singlestranded oligonucleotides featuring a T, RNAi sense, nine base pair hairpin (TTCAAGAGA), RNAi antisense and a 3′ overhang AGCT for XhoI cloning were ordered (Integrated DNA Technologies) and annealed. For α7 shRNAs singlestranded oligonucleotides featuring the RNAi sense, 10-base pair hairpin (CTTCCTGTCA), RNAi antisense and 3′ overhang ATTTTT (shRNA 1 and 3) or GTTTTT (shRNA 2) were ordered (Integrated DNA Technologies) and annealed. The annealed oligonucleotides were ligated into pAAVdsRed-Sico using HpaI and AbsI (for SCR shRNA), HpaI and XhoI (β4 and α7 shRNAs). Proper ligation was visualized by PCR amplification over the ligation region using the forward primer (ACATGGTCCTGCTGGAGTTC) and reverse primer (CCAGCTTGGTTCCCAATAGA). The same primers were used to sequence the plasmid to ensure proper ligation.
After ligation of shRNAs into pAAV-dsRed-Sico, plasmids were packaged into adeno-associated viruses (AAV2) as previously described (Mineur et al., 2011 (Mineur et al., , 2016 . This resulted in 100-200 μl of each purified virus, which was stored at 4°C.
| Stereotactic viral infusions
For validation of Cre-specific β4 knockdown, a cocktail of AAV-dsRed-Sico-β4 1 and 2 (1:1) was infused bilaterally into the MHb of adult (>8 weeks) ChAT-IRES-Cre mice or wild-type littermates. For validation of Cre-specific α7 knockdown, a cocktail of AAV-dsRed-Sico-α7 shRNA1, 2 and 3 (1:1:1) or AAV-dsRed-Sico-SCR shRNA was infused bilaterally into the vHipp of GAD65-Cre mice. For behavioural feeding experiments a cocktail of AAV-dsRed-Sico-β4 shRNA1 and 2 (1:1), a cocktail of AAV-dsRed-Sico-α7 shRNA1, 2 and 3 (1:1:1) or AAV-dsRed-Sico-SCR was infused bilaterally into the ARC of adult (>8 weeks) POMCCre or AgRP-Cre mice.
Surgery was performed using isoflurane anaesthesia, and all infusions were performed using stereotaxic coordinates empirically derived from pilot surgeries guided by a mouse brain atlas (Paxinos & Franklin, 2004 ) using a stereotaxic surgical apparatus (Kopf Instruments, Tujunga, CA). Coordinates (from bregma) for the MHb were: (2 infusions were done on each side) AP −1.4 and −1.8 mm, ML 0.25 mm on first side, 0.3 mm on the second side, DV −2.6 mm; for vHipp: AP −3.0 mm, ML ± 3.0 mm, DV −3.2 mm; for ARC: AP −0.9 mm, ML ± 0.3 mm, DV −6.0 mm. All infusions were pressure injections done with pulled glass pipettes (inner diameter of 10-40 μm) and 0.5-0.7 μl of virus was infused at each site. The pipette was left in place for 5-6 min before being withdrawn.
Animals were monitored until completely alert, returned to their home cages and monitored post-operatively for 72 hr. Animals were administered post-operative analgesia via intraperitoneal injection on the day of surgery and once per day for the next 48 hr.
| Knockdown validation
| β4 subunit knockdown
To verify knockdown, a cocktail of the two shRNA constructs targeting the β4 subunit were injected bilaterally into the MHb of ChAT-Cre mice, as the β4 subunit is highly expressed in the MHb and a large proportion of the ventral MHb cells express ChAT. ChAT-IRES-Cre mice and their wildtype littermates infused with either AAV-dsRed-Sico-β4 shRNAs or AAV-dsRed-Sico-Scr shRNA were killed 12 weeks after surgery by decapitation, and brains were removed and immediately frozen in isopentane chilled in a dry ice-ethanol bath. 200-μm-thick GFP-containing sections were taken using a NIGHTSEA BlueStar flashlight and filter goggles (Electron Microscopy Sciences, Hatfield, PA) to visualize GFP. Sections were mounted on glass slides, and 1-mm diameter punches of GFP-enriched MHb from the frozen sections were taken under LED visualization. 4-6 punches were obtained from each animal. Four animals with off-target GFP expression were excluded from analysis. Punches were stored on dry ice and subsequently at −80°C until RNA extraction.
For β4 subunit knockdown, expression of dsRed (as determined by qPCR Ct value) was used to determine viral infection, and samples with >2 cycle differences (after normalizing to tbp1) from the group mean were excluded. This resulted in n = 3 for wild-type mice, and n = 4 for ChAT-IRES-Cre mice. In Cre+ mice, expression levels of β4 mRNA detected by real-time qPCR were significantly reduced compared with Cre-animals (Supporting Information Figure S2 : t(5) = 6.488, p = 0.0013). In the same animals, β2 subunit expression was not significantly altered, indicating the specificity of the construct.
| α7 subunit knockdown
To validate the α7 subunit knockdown constructs in vivo, a cocktail of the AAVs containing the three shRNAs was injected bilaterally into the vHipp of GAD-Cre mice, as GABAergic cells in this region express high levels of the α7 subunit. GAD-Cre mice infused with either AAV-dsRedSico-α7 shRNAs or AAV-dsRed-Sico-Scr shRNA were allowed to recover for 5 weeks and were killed by decapitation. Brains were removed and sectioned using a brain block (Zivic Instruments), and slices containing the hippocampus were transferred to ice-cold phosphate-buffered saline. Virally infected regions of the hippocampus were identified using a NIGHTSEA BlueStar flashlight and filter goggles (Electron Microscopy Sciences, Hatfield, PA) and 1.2 mm diameter punches of GFP-enriched hippocampus were taken under LED visualization. Six punches were obtained from each animal, three from each hemisphere. Left and right hippocampi were kept separate and treated as individual replicates. Punches were stored on dry ice and subsequently at −80°C.
Samples that did not yield visible PCR products for GFP and dsRed, when run on a 1.5% agarose gel were consistent with samples in which GFP was not visualized during tissue dissection. These samples were considered to be off target and were excluded from analysis (2 hippocampi). This resulted in n = 6 GAD-Cre hippocampi with SCR shRNA, and n = 8 GAD-Cre hippocampi with α7 shRNA. Compared to GADCre mice injected with a SCR virus not targeting any specific mRNA, expression of α7 subunit mRNA was reduced by approximately 50% in the hippocampus of GAD-Cre mice that received the viral knockdown cocktail (Supporting Information Figure S3 : t(12) = 4.43, p = 0.0008). As with the β4 subunit knockdown, expression levels of β2 subunit mRNA were not significantly changed compared with controls.
| Assessment of food intake
Mice were single housed one week before experimental manipulations or at the time of surgery. Body weight and food weight were measured daily for the duration of behavioural experiments. Mice were allowed to recover for 6 weeks after surgery to ensure receptor turnover and effective nAChR subunit knockdown. Mice were acclimated to saline injection until animals consistently ate a minimum of 0.7 g of food in the 2 hr window as described in the feeding paradigm below. After acclimation, mice were randomized to receive saline, nicotine (0.5 mg/kg) or cytisine (1.5 mg/kg) in one of six possible presentation orders, and the feeding paradigm was repeated in successive rounds until all animals received each drug. Following completion of all successive rounds, mice were again randomized and the procedure was repeated for higher doses of nicotine (1.0 mg/kg) and cytisine (3.0 mg/ kg). If control mice receiving saline did not eat an average of 1.0 g of food in the 2 hr window as a group, all data from that round were excluded from analysis and repeated after the completion of remaining planned rounds of the sequence at that dose.
The feeding paradigm consisted of a 48-hr window beginning with a 0.1 ml intraperitoneal saline injection and removal of food at 5 p.m. Twenty-four hrs later, animals received an intraperitoneal injection of drug or saline. Fifteen minutes after injection, food was returned to the cage. Food weight was measured 2 and 24 hr later. Mice were allowed to recover for 5 days to regain their initial free-feeding body weight before any changes in food intake were tested again.
| Tissue processing and immunohistochemistry
Wild-type animals used for ARC immunohistochemistry were deeply anaesthetized via intraperitoneal injection of an overdose of pentobarbital (130 mg/kg; Fatal Plus, Patterson Veterinary), transcardially perfused with ice-cold PBS followed by 4% paraformaldehyde. Brains were removed, postfixed overnight in the same fixative, then cryoprotected in 30% sucrose. 40-μm-thick sections were cut on a sliding microtome and collected in series, with each series offset by five slices. Slices containing the ARC from one series were stained for POMC and ChAT expression. Sections were washed three times for 5 min in PBS, then blocked in 3% normal donkey serum (Jackson Immunoresearch Laboratories, Inc., West Grove, PA) in PBS with 0.3% Triton X-100 (PBST). Sections were then incubated in primary antibody (rabbit anti-POMC precursor, Phoenix Pharmaceuticals H-029-30, 1:3,000; Goat anti-Choline Acetyltransferase, Millipore Sigma AB144P, 1:1,000) overnight at room temperature in PBST. After three 8 min washes, sections were incubated in secondary antibody (Donkey anti-rabbit IgG-Alexa Fluor 555, Thermo Fisher Scientific A-31572, 1:1,000; Donkey anti-Goat AlexaFluor 647, Life Technologies A-21447, 1:1,000) in PBST for 2 hr at room temperature, then washed three times, mounted and cover slipped with Fluoromount G (EMS, Hatfield, PA).
After completion of all behavioural experiments, tissue was collected from POMC-Cre and AgRP-Cre mice as described above. Three to four slices containing the ARC (one series) from each mouse were stained for the virally expressed fluorophores dsRed and GFP to verify proper targeting. Sections were stained using the same protocol as above with rabbit polyclonal anti-dsRed (Clonetech 632496, 1:1,000) and goat polyclonal anti-GFP (Abcam ab6673, 1:1,000) primary antibodies followed by donkey anti-Rabbit IgG AlexaFluor 555 (Thermo Fischer Scientific A-31572, 1:1,000) and donkey anti-Goat Alexa Flour 488 (Thermo Fisher Scientific A-11055, 1:1,000) secondary antibodies.
Sections were visualized on a confocal microscope (Fluoview FV10i, Olympus). AgRP-and POMC-Cre animals with viral expression in the ARC and appropriate viral recombination indicated by the presence of red-only cells were considered to be targeted appropriately. All animals that did not meet this criterion, independent of which virus was infused, were combined to generate an "off-target control" group for analyses.
| Statistics
Data are presented as box plots representing the min, max and quartile values of the group or as bar graphs showing the mean and SEM. Enrichment for bacTRAP qPCR samples was compared with paired t tests, and differences between AgRP-and POMC-TRAP mRNA expression were compared with unpaired t tests. Relative protein expression in IP experiments was compared with unpaired t tests. A one-way ANOVA with Holm-Sidak post hoc correction of the planned comparisons was used to determine β4 subunit binding partners with sequential IP. For food intake of wildtype animals, a one-way, repeated measures ANOVA with planned comparisons was used to compare effects of nicotine and cytisine to saline control. A two-way, repeated measures ANOVA with planned comparisons of active drug (nicotine or cytisine) to saline, within viral treatment group, was used for shRNA mediated knockdown feeding experiments. AgRP-Cre and POMC-Cre mice were analyzed separately. Holm-Sidak post hoc corrections were used to determine significance. p or adjusted p of ≤0.05 was regarded as significant. Statistical analyses were carried out using Graph Pad Prism 8.
| RESULTS
| nAChR subunit mRNA representation in ARC
As an initial step to identify the nAChR subunits expressed in ARC we used reverse transcription, qualitative PCR to determine whether the mRNAs encoding each of the neuronal nAChR subunits were expressed in the ventral hypothalamus. All nAChR subunits except the α2 subunit were detected in this experiment (Figure 1a ). For cell type-specific mRNA expression, we used quantitative real-time PCR analysis (qrtPCR) of mRNA isolated from whole hypothalamus and mRNA isolated using TRAP from either AgRP or POMC cells. We determined whether mRNA for individual nAChR subunits were enriched in the pool of actively transcribed mRNA from either cell type over the concentration of all mRNAs found in the hypothalamus in general, and if there were differences in relative concentration of translating mRNA for any subunit between these two cell populations.
As with the qualitative PCR from mRNA obtained from ventral hypothalamic punches (Figure 1a) , the majority of nAChR subunits were detectable in the hypothalamic input fraction, although transcripts encoding the β3 subunit were not consistently detected in either the input fraction or the TRAP-isolated mRNA from either cell type (Figure 1) . Further, while the α2 subunit was not detectable in the PCR samples derived from a single mouse, it was identified in the hypothalamic tissue pooled from multiple animals. However, like the β3 subunit, the α2 and α5 subunits were not detected reliably in TRAP-isolated mRNA from either AgRP or POMC cells (data not shown), indicating that while mRNAs encoding these three fairly low abundance subunits are expressed in the hypothalamus, they are not represented in the pool of actively transcribed mRNAs in AgRP or POMC cells of the ARC.
The majority of detectable subunits were enriched in both AgRP and POMC cell types when the TRAP fractions were normalized to mRNA concentrations in the whole hypothalamic homogenate (input fraction), which would include other neuronal subtypes as well as multiple glial and
endothelial cell types (Figure 1b-d) . The α4 and α6 subunits showed the most robust enrichment over the hypothalamic input fraction in both AgRP and POMC cells with group median values between 20 and 30 fold enrichment (Figure 1b ; α4: AgRP, t(6) = 6.453, p = 0.0001; POMC, t(9) = 5.841, p = 0.0002; α6: AgRP, t(6) = 2.951, p = 0.0256; POMC, t(8) = 8.564, p < 0.0001). Both the β4 and α3 subunits were significantly enriched in TRAP mRNA from both POMC and AgRP cells as well (Figure 1c ; β4: AgRP, t(3) = 4.016, p = 0.0277; POMC, t(4) = 4.788, p = 0.0087; α3: AgRP, t(6) = 3.09, p = 0.0214; POMC, t(7) = 10.42, p < 0.0001). Finally, the β2 subunit was enriched about 3 fold in both AgRP and POMC cells (Figure 1d : AgRP, t(7) = 6.618, p = 0.0003; POMC, t(9) = 4.812, p = 0.0010). Unlike the other detectable subunits, the α7 subunit was not enriched in the AgRP or POMC cell types. While qPCR CT values indicated high levels of expression in both the TRAP and input fractions (Ct values around 18), TRAP-isolated α7 mRNA was significantly reduced in AgRP neurons compared with the input and there was a trend for reduction of this mRNA in POMC cells (Figure 1e : AgRP, t(7) = 5.227, p = 0.0012; POMC, t(8) = 2.089, p = 0.0701). This result suggests that α7 mRNA is highly expressed in other cell types in ARC in addition to the AgRP and POMC cells.
When concentrations of mRNAs encoding nAChR subunits were compared between AgRP and POMC cells directly, only transcripts encoding two of the six detected subunits differed between the cell types. As suggested by the enrichment comparison, mRNA for the α7 subunit is more highly expressed in POMC cells compared with AgRP cells (Figure 1f ; t(16) = 2.488, p = 0.0243). Further, there was a trend towards a difference in expression of mRNA encoding the α4 subunit, with higher expression in AgRP cells ( Figure 1 g; t( 18) = 2.092, p = 0.0509). No differences in transcript levels between POMC and AgRP cells were detected for α3, α6, β2 or β4 (data not shown).
| Levels of nAChR subunit proteins in ARC
Although mRNA levels are informative about proteins transcribed in neurons with cell bodies in ARC, mRNA levels do not always correspond well with protein levels (Carlyle et al., 2017) , and not all protein subunits may be incorporated into assembled receptors. To understand which nAChR subunits are incorporated into assembled nAChRs expressed in the ARC itself and not trafficked out to terminals, we performed IP from hypothalamic homogenates after isolating assembled
F I G U R E 1 Expression of nAChR subunit mRNA in the hypothalamus and actively translated mRNAs isolated from AgRP or POMC neurons. (a) Ethidium bromide gel visualization of nAChR subunit PCR products from an ARC-enriched punch of ventral hypothalamus. (b-e)
TRAP-isolated nAChR subunit mRNA levels from AgRP (white) or POMC (grey) neurons normalized to the respective whole hypothalamic input fraction. Input and TRAP fractions were compared with paired t tests. (f, g) Direct comparison of TRAP-isolated α7 (f) and α4 (g) mRNA from AgRP and POMC cells. AgRP and POMC-TRAP expressions were compared with unpaired t tests. Data are expressed as fold change from the reference group (Input b-e or POMC f, g), which is mathematically defined as 1 (noted with a dashed line). Box plots represent min, max and quartiles, n = 6-10, as noted. *p < 0.05, **p < 0.01, ***p < 0.001 heteromeric nAChRs by [ 3 H]-Epibatidine binding. All the tested nAChR subunits (α2-6, β2-4) were detectable in a crude dissection of hypothalamic tissue, and all but the α2 subunit were detectable above background in a more specific punch of hypothalamus containing the ARC ( H]-Epibatidine binding allowed for a relative comparison of how much of the total signal is accounted for by each subunit. When compared directly, signal from the α3 subunit makes up a greater percentage of the total ARC signal compared with the hypothalamus as a whole (t(4) = 3.52, p = 0.0245). Similarly, signal for the β4 subunit trended in the same direction (t(5) = 2.216, p = 0.0775). Conversely, the α4 and β2 subunits appeared to account for a smaller proportion of the signal in the ARC compared with the hypothalamus overall (α4, t(3) = 2.0279, p = 0.0720; β2, t(4) = 2.077, p = 0.1064). The other nAChR subunits represented approximately the same proportion of the signal in both the total hypothalamus and the more specific ARC sample.
Evidence that the β4 subunit is expressed in the hypothalamus is clear from examining its expression in the hypothalamus of β2 nAChR subunit knockout mice (Table 3) . As expected, the [ 3 H]-Epibatidine signal is much lower in homogenates from the β2 knockout mice compared with homogenates from wild-type mice because of the loss of the more abundant β2 nAChR subunit. However, when raw radioactivity counts are normalized to total [ 3 H]-Epibatidine binding in each sample, β2 signal is reduced to background levels in homogenates from knockout mice (t(4) = 20.82, p < 0.0001) and relative α4 subunit incorporation into assembled nAChRs is dramatically reduced (t(5) = 14.87, p < 0.0001). Incorporation of the α5 subunit is also reduced in nAChRs isolated from β2 knockout mice (t(3) = 3.419, p = 0.0419). Further, both the α3 and β4 subunits make up a significantly larger percentage of the total nAChR signal in the hypothalamus from β2 knockout mice (α3 t(4) = 4.128, p = 0.0145; β4 t(5) = 5.737, p = 0.0023).
As the β4 nAChR subunit is more highly expressed in ARC compared with the rest of the hypothalamus, sequential IP were performed to understand which nAChR subunits incorporate with this subunit to form assembled nAChRs in the ARC. To perform this experiment, an initial IP was performed with the antibody for the nAChR subunit of interest, then the supernatant from this IP was used for the second IP with the β4 antibody. These results are summarized in Table 4 . As an internal control, two sequential IP were performed with the β4 antibody, which reduced the signal in the second IP to near zero, indicating that the majority of the β4 subunits in the sample had been bound and removed in the first IP. For comparison, if a sequential IP was not significantly different from this internal control, then this was considered evidence for subunit interactions and binding in assembled channels. A one-way ANOVA indicated that signal from some subunits did differ from the β4-β4 control (Table 4 ; F 8,7 = 7.753, p = 0.0074). Based on Holm-Sidak adjusted post hoc comparisons, IP for the α3 subunit followed by β4 IP was not different from the β4-β4 control, suggesting that these two subunits co-assemble, as expected (Grady et al., 2009) . β4 signal was also reduced when the first IP was performed with antibodies against α4 or β2 nAChR subunits, but signal was not reduced and remained significantly higher than β4-β4 control levels after first IP with antisera against the α2 (adjusted p = 0.0284), α5 (adjusted p = 0.0141), α6 (adjusted p = 0.0147), or β3 (adjusted p = 0.087) subunits. Based on these data, β4 subunits assemble into nAChRs with α3, α4, and β2 subunits, but not α2, α5, α6 or β3 subunits in the ARC. In a small follow up experiment (n = 1), sequential IP with the β2 subunit antibody after either the α3 or β4 subunit showed that the percentage of total [ 3 H]-Epibatidine binding is greatly reduced, consistent with the described interaction with β4 and suggesting that β2 also combines with the α3 in assembled nAChRs in ARC, as has been shown in other brain areas (Grady et al., 2009 ). This analysis indicates that either β4 or β2 may be acting as an auxiliary subunit in α4β2* or α3β4* channels, respectively.
| Expression of cholinergic markers in the ARC
In addition to testing the levels of translated nAChR subunits in TRAP mRNA samples, we also measured expression of choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) mRNAs, two enzymes in the ACh synthesis and packaging pathway commonly used as markers for cholinergic neurons. Previous studies have ascribed a cholinergic phenotype specifically to POMC neurons in this region (Meister et al., 2006 ), but we found that mRNAs encoding ChAT and VAChT were enriched in both AgRP and POMC cells when compared to expression in the hypothalamic input (Figure 2a : AgRP, t(6) = 6.972, p = 0.0004; POMC, t(9) = 5.346 p < 0.0005). In addition, when compared to POMC neurons directly, AgRP neurons express these mRNAs at a 2-3 fold higher concentration (Figure 2b : ChAT t(15) = 3.561, p = 0.0028; VAChT t(14) = 7.549, p < 0.0001). Consistent with mRNA measurements, immunohistochemistry for ChAT protein in the ARC revealed that ChAT protein is expressed not only in POMC cells in ARC (white arrowheads), but also in other cells in the ARC that do not express POMC (white arrows; Figure 2c ).
| Relative role of β4 and α7 nAChR subunits in the ARC in the feeding response to nicotine and cytisine
To examine the effect of nAChR agonists on food intake, we used a repeated measures feeding paradigm in which animals were food deprived for 24 hr then injected with saline, nicotine or cytisine in a randomized order before returning food to their home cage. Food intake was measured 2 and 24 hr after each treatment. Both nicotine and cytisine reduced food intake at 2 hr compared with saline administration in this acute feeding paradigm (Figure 3a ; repeated measures ANOVA F 2,20 = 4.273, p = 0.0285, post hoc nicotine versus saline adjusted p = 0.0317, cytisine versus saline adjusted p = 0.0269). There were no differences in 24 hr food intake (data not shown).
To gain understanding of nAChR subunits in POMC and AgRP cells in the control of food intake in response to these nicotinic drugs, we developed cell type-selective shRNA viral constructs designed to target either the β4 or α7 nAChR subunit (Figure 3b ). After verification, viral knockdown cocktails were injected bilaterally into the ARC of AgRP-or POMC-Cre mice to knockdown either subunit in one cell type selectively, rather than all neuronal cell types in the ARC. In the absence of Cre expression, both dsRed and GFP are expressed, while recombination in the presence of Cre leads to excision of GFP and expression of the shRNA construct. A representative image of bilateral ARC injection and the resulting recombination are shown in Figure 3c . Virally injected mice were singly housed and weighed daily F I G U R E 3 The effect of nicotine and cytisine on food intake in wild-type mice and after cell type-selective knockdown of either the β4 or α7 nAChR subunit. (a) Two-hour food intake in wild-type mice following saline (white), cytisine (1.5 mg/kg, grey) or nicotine (0.5 mg/kg, pink) intraperitoneal injection. Drug order was randomized for a within-subjects analysis. One-way ANOVA compared cytisine and nicotine intake to saline intake. Box plots represent min, max and quartiles; saline = white, nicotine = pink, cytisine = grey, n = 11. (b) Diagram of the AAV plasmid vector used to deliver shRNA knockdown constructs (top) for either β4 or α7 nAChR subunit into the ARC (bottom). In the absence of Cre-recombinase, cells will express both dsRed and eGFP, while in the presence of Cre-recombinase, the GFP encoding DNA is excised, allowing the U6 promotor to drive shRNA expression in red-only cells. (c) Representative image of bilateral AAV expression in the ARC at 10× (top) and individual fluorophore expression (bottom) at 60x. Cells in which successful infection and recombination have taken place express dsRed, but not GFP (white arrows). Cells which are infected, but do not express Cre-recombinase express both dsRed and GFP and appear yellow in the merged image. 3V = 3rd Ventricle, ARC = arcuate, ME = median eminence, 10x scale bar = 100 μm, 60× scale bar = 50 μm. (d) Two-hour food intake in POMC-Cre (left) or AgRP-Cre (right) mice with shRNA knockdown of either β4 or α7 nAChR subunit following saline (white), cytisine (3.0 mg/ kg, grey) or nicotine (1.0 mg/kg, pink) IP injection. Drug order was randomized for a within-subject analysis. Two-way ANOVAs with planned post hoc comparisons of cytisine and nicotine to saline intake within knockdown group were used. Box plots represent min, max and quartiles; n = 7-12, as noted. *p < 0.05, **p < 0.01, ***p < 0.001 for 6 weeks before the start of behavioural experiments to allow for viral expression and nAChR protein turn over. Body weight between groups did not differ at the time of surgery or after the 6 week viral incubation period in either AgRPor POMC-Cre mice (data not shown). After habituation to the feeding paradigm, animals were food deprived for 24 hr then injected with saline, nicotine or cytisine in a randomized order for a within-subject comparison of food intake. A repeated measures ANOVA indicated a main effect of drug in both POMC-and AgRP-Cre animals (POMC: F 2,124 = 16.91, p < 0.0001; AgRP: F 2,118 = 9.894, p = 0.001) at the 2 hr time point, but not at 24 hr (data not shown), but no significant main effects of knockdown condition or interaction were observed. Planned comparisons of drug (cytisine or nicotine) to saline within knockdown condition and cell type revealed significant differences in food intake in some, but not all viral groups (Figure 3d) .
Knockdown of the β4 subunit in POMC neurons blunted the ability of cytisine and nicotine to decrease food intake compared with saline treatment as animals with β4 knockdown did not eat significantly less after cytisine or nicotine than they did with saline (adjusted p > 0.05). For both drugs, the reduction in food intake following β4 subunit knockdown in POMC neurons was not statistically significant, indicating at least a partial blockade of the effects of cytisine and nicotine by β4 knockdown in POMC cells of the ARC. Interestingly, β4 subunit knockdown in AgRP neurons was also sufficient to block the decrease in feeding caused by cytisine and nicotine (adjusted p > 0.05). In contrast to β4 knockdown, knockdown of the α7 subunit in POMC cells did not decrease the anorectic effects of nicotine or cytisine, as both drugs significantly reduced food intake compared with saline (cytisine, adjusted p = 0.0066, nicotine, adjusted p = 0.0010). α7 knockdown in AgRP cells also did not block the decrease in feeding due to nicotine (adjusted p = 0.0079). There was a trend for reduction of two-hour food intake in response to cytisine compared with saline food intake, although this decrease did not reach significance (adjusted p = 0.0567).
In addition to β4 and α7 knockdown, a subset of AgRPand POMC-Cre animals were infused with AAV2 carrying a scrambled (SCR) shRNA (Supporting Information Figure  S4 ). There was a trend for cytisine and nicotine to decrease food intake in these groups. In POMC-Cre animals, cytisine trended to decrease intake (adjusted p = 0.0636), while the effect of nicotine was not as robust (adjusted p = 0.1392). In AgRP animals, those with the SCR KD treated with saline had the lowest intake of any group, and there was not a robust further decrease in intake after cytisine or nicotine, potentially indicating a floor effect in this group. Because of the small size of the ARC, in all groups there were numerous animals in which the injected virus was off-target and viral expression was observed in other parts of the hypothalamus, with no expression or recombination in the ARC (Supporting Information Figure S4b ). These animals were pooled and analysed as an off-target control group. Nicotine and cytisine significantly decreased food intake compared with saline in both AgRP-and POMC-Cre off-target animals (POMC adjusted p < 0.0001 for both drugs, AgRP adjusted p < 0.0001 for both drugs), indicating that both nicotine and cytisine do reduce intake at baseline in this paradigm in these mouse lines.
| DISCUSSION
The data presented here suggest that the effects of nAChR signalling in the ARC are significantly more complex than was originally hypothesized, particularly in the control of feeding regulation by nicotinic compounds. Numerous nAChR subunits are expressed in hypothalamus (α2-α7, β2-β4) at the mRNA level, with a subset of these selectively enriched in ARC AgRP and POMC neurons (α3, α4, α6 and β2, β4) . While high levels of the α7 subunit mRNA were detected, this subunit was not significantly enriched in either AgRP or POMC cells above levels detected in the rest of the hypothalamus. Surprisingly, there was not dramatic cellular segregation in nAChR expression, with no differences between cell types detected in expression of α3, α6, β2 or β4 subunits. mRNA encoding the α4 subunit trended towards higher levels in AgRP compared with POMC neurons and α7 subunit mRNA levels were significantly higher in POMC neurons. At the protein level, the same set of nAChR subunits were detected (excluding α7, which was not tested because specific antisera are not available) in both the hypothalamus overall and in an ARC-enriched fraction of hypothalamus. Compared to the hypothalamus overall, a higher proportion of nAChR signal included the α3 subunit in the ARC, with a trend towards ARC enrichment for the β4 subunit as well. In contrast, the β2 and α4 subunits showed a trend to make up less of the nAChR signal in the ARC compared with the overall hypothalamus, indicating region-selective expression of particular nAChR subunits. Further, consistent with a previous report (Picciotto et al., 1995) deletion of β2 subunit eliminates approximately 90% of the high affinity [ 3 H]-Epibatidine binding in the hypothalamus, and a higher percentage of the remaining receptors contain the α3 and β4 subunits, thus confirming that the α3 and β4 signal observed in wild-type animals is specific.
A subset of ARC neurons express the enzymes necessary to synthesize and package ACh, indicating the potential for local ACh synthesis and release in this brain area. Both AgRP and POMC neurons express mRNA encoding ChAT and VAChT, with AgRP neurons expressing comparatively more than POMC neurons. At the protein level, both POMC-positive and POMC-negative neurons express ChAT. With respect to food intake, while knockdown of
the β4 subunit appears to diminish the behavioural feeding response to nicotine and cytisine relative to knockdown of the α7 subunit, the behavioural responses appear to be similar when these subunits are knocked down in AgRP versus POMC cells. Knockdown of the β4 subunit in AgRP-Cre mice blocks the decrease in food intake caused by nicotine and cytisine, and similarly, when the β4 subunit is knocked down in POMC neurons the decrease in food intake is blunted, though not completely abolished. Following knockdown of the α7 subunit in either cell type, the decrease in feeding due to cytisine or nicotine is significantly more robust than in either line after knockdown of the β4 subunit.
The distinct function of AgRP and POMC cells in the control of food intake has been confirmed clearly in recent optogenetic studies, which identify rapid and dramatic increases in food intake following stimulation of AgRP neurons and decreased food intake following stimulation of POMC cells (Aponte et al., 2011; Atasoy, Betley, Su, & Sternson, 2012; Betley, Cao, Ritola, & Sternson, 2013; Fenselau et al., 2016; Krashes et al., 2011) . A number of recent studies have evaluated broad gene expression profiles of AgRP or POMC neurons using RNA-Seq (Henry, Sugino, Tozer, Branco, & Sternson, 2015; Lam et al., 2017) or more targeted gene profiling techniques (Jeong, Woo, Chua, & Jo, 2016) . These studies did not isolate actively translated mRNAs, like the TRAP method used here, nor did they focus on nAChRs. Although not the explicit focus of the analysis, Henry et al. (2015) did identify a number of nAChR subunit mRNAs in both AgRP and POMC cells. As in the current study, they also identified mRNAs encoding the α3, α4, and α7 and β2 and β4 subunits, and even in this genomewide study, identified a difference in α4 and α7 mRNA levels between AgRP and POMC cells when animals were in a fed state, in the same directions observed here. Consistent with the current TRAP study, they saw no differences in levels of mRNAs encoding the other nAChR subunits between AgRP and POMC cells. However, in the genomewide study they did not identify mRNAs encoding α2, α5, α6 or β3 nAChR subunits, likely because these transcripts are present at lower levels and the experiment was not designed to detect this population of molecules specifically. Interestingly, this study suggested that transcripts encoding the α4 nAChR subunit are decreased in AgRP neurons when animals are food deprived compared with a fed state, indicating potential dynamic regulation of nAChR mRNA levels, although it is not known whether the proportion of actively translated mRNA differs. Notably, difference in nAChR stoichiometry can change receptor function such that (α4β2) 2 α4 receptors have higher channel conductance, shorter open times and lower agonist sensitivity than (α4β2) 2 β2 receptors (Lucero et al., 2015; Mazzaferro et al., 2016; Papke, Wecker, & Stitzel, 2010) , thus differences in α4 subunit levels could alter nAChR channel dynamics.
In a single-cell RNA-Seq study that focused on POMC neurons (Lam et al., 2017) , only α4 was listed among nAChR subunit mRNAs in the supplemental list of transcripts. Interestingly, in the four clusters of POMC cells they defined based on gene expression profiles, the α4 subunit ranged in expression from 3.7% of cells up to 20% of cells, indicating that α4 mRNAs are not homogenous in all cells that express POMC. This experiment also showed that a portion of POMC cells also expresses low levels of AgRP transcript, and vice versa. Thus, the differences in translated nAChR subunit mRNAs between AgRP and POMC cells identified here may be due to a difference in the relative proportion of AgRP or POMC cells actively transcribing these subunits, and a single-cell approach could provide necessary insights into subpopulations within these broad peptide-defined categories of cells. Another single-cell qPCR study confirms this heterogeneity within cells of the ARC (Jeong et al., 2016) .
Of the 26 ARC cells tested, all expressed mRNA encoding ChAT, whereas expression of mRNAs encoding α4, α7, and β2 nAChR subunits varied across cells, with some cells expressing all three subunits, some a combination of one or two subunits, and some cells did not express any nAChR subunit mRNAs at all. Further, of these ChAT-positive cells, only about half expressed mRNA encoding POMC, consistent with the data presented here that POMC cells and non-POMC cells express ChAT protein. This confirms previous reports describing POMC neurons as cholinergic in the ARC (Meister, 2007; Meister et al., 2006) , but shows that the translation of cholinergic markers is not confined to this cell type. While the current study shows expression of ChAT and VAChRT mRNA in POMC and AgRP cells and ChAT protein in POMC and non-POMC cells, Meister et al. (2006) , showed that ChAT protein did not overlap with NPY protein in the ARC. It is possible that post-translational modification in AgRP neurons results in translational blockade or degradation of ChAT or VAChT proteins, and that POMC-negative/ ChAT-positive cells in ARC represent another cell type entirely. Therefore, these POMC-negative/ChAT-positive cells shown in Figure 2 may represent an entirely different neuronal cell type in the ARC, such as tyrosine hydroxylaseexpressing neurons, which have been described in this region (Zhang & van den Pol, 2015 .
While not every AgRP or POMC cell may express each nAChR subunit, the cells that do express these subunits form receptors in combinations that are unique compared with other brain areas. Although α3β4* receptors are the primary nAChR in autonomic ganglion neurons, the expression of this type of nAChR in the brain is significantly more limited, with highest expression in the MHb and its output nucleus the interpeduncular nucleus (IPN; Dineley-Miller & Patrick, 1992) . Despite its presence at lower levels, the current study and others (Henry et al., 2015; Herman et al., 2016; Mineur et al., 2011) show expression of β4-containing nAChRs in the ARC. Interestingly, the composition of β4 subunitcontaining nAChRs in the ARC differs from subtypes in the MHb and IPN. In the MHb, β4* receptors make up about half of the nAChR population, while in the IPN, there are more β4* receptors than β2* receptors (Grady et al., 2009 ). In the hypothalamus, β4 subunits represent 6% of the nAChR population, and this percentage increases to 14% in the ARC, indicating an anatomically selective expression in this part of the hypothalamus. In all these brain regions, as in the autonomic ganglion, the predominant partner of β4 in assembled nAChRs is the α3 subunit.
The current study shows that the β4 subunit also forms nAChRs with the α4 and β2 subunits in ARC. While the β2 and β4 subunits contribute to independent nAChR populations in MHb and IPN, α3β4β2* receptors have been described in the autonomic ganglia (Stokes & Papke, 2012) . Unlike in the MHb or IPN, the β4 subunit does not form channels with the α2 or α6 subunit in ARC. Further, β4 subunits in the ARC do not form channels with the auxiliary subunits α5 and β3, which are very common partners in the autonomic ganglia (Conroy & Berg, 1995) and MHb/IPN (Grady et al., 2009) , respectively. In the IPN, α3β4* and α3β4β3* nAChRs regulate ACh release, and the β3 subunit may play an important role in regulating nAChR trafficking to axon terminals in the IPN. Further, and in contrast to β4* receptors, α4β2* receptors can regulate the release of other neurotransmitters, potentially glutamate, in the IPN (Grady et al., 2009 ). As we have no evidence for α3β4β3* nAChRs in the ARC, α3β4* nAChRs could induce ACh release in the ARC, rather than out at distal terminal regions of these neurons. It is important to note that these immunoprecipitation experiments identifying co-assembled nAChR subunits cannot differentiate between nAChRs on neurons with cell bodies in the hypothalamus and nAChRs on axons from other brain areas terminating in the ARC. However, because there is consistency between translating mRNA and protein data in these experiments, at least a large subset of identified nAChRs are made and expressed by cells within the ARC.
The precise subunit combinations that make up each nAChR subtype dramatically affects channel properties and function, but also confers selectivity for different nicotinic drugs. Nicotine alters the electrophysiological excitability (Huang et al., 2011; Mineur et al., 2011) , and neuropeptide expression levels (Calarco, Lee, & Picciotto, 2017; Chen, Saad, Sandow, & Bertrand, 2012; Fornari et al., 2007; Frankish et al., 1995; Hur, Hong, Choi, Shin, & Chun, 2010) in both AgRP and POMC neurons in ARC. Nicotine application results in depolarization of both AgRP and POMC cells with components that are sensitive to both the β2*-selective antagonist DhβE-and the α7-selective antagonist MLA (Huang et al., 2011) . Nicotine increases the firing frequency in both AgRP and POMC cells, and cytisine increases the firing frequency of POMC cells, whereas effects on AgRP neurons have not been evaluated. While nicotine is an agonist at all nAChR subtypes, cytisine is a full agonist at both α3β4* and α7 nAChRs, and a low-efficacy partial agonist at α4β2* nAChRs in mice. In POMC neurons, both nicotine and cytisine cause a comparable increase in cell firing and both drugs result in a similar decrease in feeding, which is dependent on signalling through the MC4 receptor, the downstream target of both AgRP and α-MSH, a POMC derivative (Mineur et al., 2011) . Knockdown of the β4 receptor in the ARC was sufficient to block the reductions in food intake caused by cytisine (Mineur et al., 2011) , and in the current study knockdown in either AgRP or POMC cells blunted the reduction in feeding due to cytisine and nicotine. Conversely, knockdown of the α7 subunit in either cell type did not alter the feeding response to cytisine or nicotine. While α7 is highly expressed in the hypothalamus and may regulate other circuits controlling food intake (Jo, Wiedl, & Role, 2005; McFadden, Cornier, & Tregellas, 2014) , based on these data, it appears to be unlikely that α7 regulates food intake in response to nicotine through AgRP or POMC neurons. Notably, our TRAP studies showed that α7 mRNA was enriched in other cell types in ARC compared with AgRP or POMC neurons, suggesting that signalling through this nAChR subtype occurs on as-yetunidentified cell types. Interestingly, the α7 subunit induces calcium waves in hippocampal astrocytes (Shen & Yakel, 2012) , suggesting that nicotinic control of glia function could alter ARC function. As glia are important regulators of neuronal energy balance (Argente-Arizón, Guerra-Cantera, GarciaSegura, Argente, & Chowen, 2017; Djogo et al., 2016; Yang, Qi, & Yang, 2015) , and activity of ARC neurons is responsive to overall energy demands (Cansell et al., 2012; Kohno & Yada, 2012; Sternson & Atasoy, 2014) , this could be an additional function for nAChR signalling that could be evaluated.
The data presented here add a new layer of complexity to this ARC feeding circuit. Not only are the comparatively rare β4* nAChRs sufficient to affect feeding behaviour in response to nicotine, their role in AgRP and POMC neurons have similar downstream results despite the fact that AgRP and POMC cells have well described opposing effects on food intake. As study of this brain circuit has increased with increasingly specific tools, it is becoming more apparent that AgRP cells and POMC cells are not uniform categories. Both AgRP and POMC neurons project to many locations, and for both cell types, a given neuron is likely to project to only one downstream target (Betley et al., 2013; King & Hentges, 2011) , indicating anatomical specificity. Further, single-cell genetic profiling studies (Jeong et al., 2016; Lam et al., 2017) show that subsets of POMC and AgRP cells have gene expression profiles that could correlate with and define their anatomical specificity. This single-cell specificity becomes even more relevant when considering that some POMC neurons express and release GABA, while others signal using glutamate, and other still have neither fast neurotransmitter but may signal exclusively through neuropeptide release (Dicken, Tooker, & Hentges, 2012; Hentges, Otero-Corchon, Pennock, King, & Low, 2009; Hentges et al., 2004; Marshall, Desroziers, McLennan, & Campbell, 2017) . Although the majority of AgRP neurons express and release GABA, neurotransmitter variety has also been observed in AgRP neurons (Horvath, Bechmann, Naftolin, Kalra, & Leranth, 1997) . Further, some AgRP and POMC neurons may also release ACh in addition to other neurotransmitters, as they express ChAT and VAChT, although no experiments to date have demonstrated ACh release from these neurons directly. Because of the unique qualities of individual AgRP and POMC cells with respect to their projections, gene expression, and neurotransmitter profile, it is plausible that β4* nAChRs may play a role in a specific subset of AgRP and POMC cells.
| CONCLUSION
These experiments demonstrate that the β4 subunit is expressed on both POMC and AgRP neurons in ARC, identify a broad range of nAChRs that are differentially present in ARC as compared to the hypothalamus as a whole and indicate a more complex interaction in the ARC with respect to nAChR signalling than was predicted. These studies are important in developing a more complete model of how nAChR activation in the ARC regulates food intake. Future experiments examining the heterogeneity of these populations are needed to understand this interaction fully. Determining the unique features of nAChR-mediated modulation of these cells with respect their gene expression, connectivity and pattern of activity will provide insight into the mechanistic control of food intake and potentially provide therapeutic targets for clinical interventions to control weight.
